Stocks Making the Biggest Moves Midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & More

March 10, 2026

TL;DR

Hims & Hers Health shares rose 3% after Novo Nordisk dropped a patent infringement case and agreed to have Hims sell its drugs.
BioNTech's U.S.-traded shares fell over 20% after co-founders announced their departure to lead a new company and the company reported a fourth-quarter net loss.
SolarEdge Technologies stock surged nearly 10% following an upgrade by Bank of America, citing stabilized financials.
Vertex Pharmaceuticals shares advanced 8% after a drug trial for IgA nephropathy met its late-stage goals.
Rivian Automotive shares jumped about 6% after a 'buy' upgrade from TD Cowen, anticipating strong demand for its new R2 SUV.
UWM Holdings advanced almost 7% after lifting its first-quarter revenue outlook.
West Pharmaceutical Services fell 6% on news of its CEO and chairman's upcoming retirement.
United Natural Foods shares lost almost 3% after reporting fiscal second-quarter revenue below expectations and lowering full-year guidance.
Kohl's shares rose 1% despite reiterating a turnaround plan, after posting disappointing fourth-quarter revenue but topping earnings estimates.
Casey's General Stores added nearly 2% despite revenue missing estimates, as its third-quarter earnings topped expectations.

Continue reading the original article